Follow The Filings

AMH

Earnings company data as of 5:07 PM ET 10/30

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS 0.16 — —
Rev $489.1M — —

Insider trades

Open-market buys and sales by AMH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All AMH insider trades
  • $207K bought by 2 insiders
  • $205K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. David Goldberg Director
    Buy
    $59K 2,000 shares at $29.30 +5.8% to stake
    Traded Mar 3 Filed Mar 9
    ↗
  2. Brian Reitz Chief Accounting Officer
    Sale
    $205K 7,000 shares at $29.34 22% of stake
    Traded Feb 24 Filed Feb 26
    ↗
  3. David Goldberg Director
    Buy
    $58K 2,000 shares at $29.17 +6.1% to stake
    Traded Feb 24 Filed Feb 26
    ↗
  4. Douglas N Benham Director
    Buy
    $58K 2,000 shares at $29.15 +6.2% to stake
    Traded Feb 23 Filed Feb 25
    ↗
  5. Douglas N Benham Director
    Buy
    $32K 1,000 shares at $31.65 +14% to stake
    Traded Nov 19, 2025 Filed Nov 21, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 39 trades in other securities, 17 stock grants, 8 share withholdings for taxes, 4 sales back to the company, 3 option exercises, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13D — Filing Doc
8-K 7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
424B5 Filing Doc
8-K 8.01,9.01 Filing Doc
424B7 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 3 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.